Modulating Treg stability to improve cancer immunotherapy

被引：80

作者：

Kang, Jee Hye ^{[1
,2
]}

Zappasodi, Roberta ^{[1
,2
]}

机构：

[1] Cornell Univ, Weill Cornell Med, Weill Cornell Med Coll, New York, NY 10065 USA

[2] Weill Cornell Grad Sch, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA

来源：

TRENDS IN CANCER | 2023年 / 9卷 / 11期

关键词：

REGULATORY T-CELLS; TRANSCRIPTION FACTOR; FOXP3; EXPRESSION; DEACETYLASE INHIBITION; RECEPTOR STIMULATION; HISTONE DEACETYLASE; TGF-BETA; TUMOR; PROMOTES; REG;

D O I：

10.1016/j.trecan.2023.07.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunosuppressive regulatory T cells (Tregs) provide a main mechanism of tumor immune evasion. Targeting Tregs, especially in the tumor microenvironment (TME), continues to be investigated to improve cancer immunotherapy. Re-cent studies have unveiled intratumoral Treg heterogeneity and plasticity, furthering the complexity of the role of Tregs in tumor immunity and immunotherapy response. The phenotypic and functional diversity of intratumoral Tregs can impact their response to therapy and may offer new targets to modulate specific Treg subsets. In this review we provide a unifying framework of critical factors contributing to Treg heterogeneity and plasticity in the TME, and we discuss how this information can guide the development of more specific Tregtargeting therapies for cancer immunotherapy.

引用

收藏

页码：911 / 927

页数：17

相关论文

共 125 条

[91] Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy [J].

Shen, Li ;

Pili, Roberto .

ONCOIMMUNOLOGY, 2012, 1 (06) :948-950

[92] Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models [J].

Shen, Li ;

Ciesielski, Michael ;

Ramakrishnan, Swathi ;

Miles, Kiersten M. ;

Ellis, Leigh ;

Sotomayor, Paula ;

Shrikant, Protul ;

Fenstermaker, Robert ;

Pili, Roberto .

PLOS ONE, 2012, 7 (01)

[93] Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma [J].

Simpson, Tyler R. ;

Li, Fubin ;

Montalvo-Ortiz, Welby ;

Sepulveda, Manuel A. ;

Bergerhoff, Katharina ;

Arce, Frederick ;

Roddie, Claire ;

Henry, Jake Y. ;

Yagita, Hideo ;

Wolchok, Jedd D. ;

Peggs, Karl S. ;

Ravetch, Jeffrey V. ;

Allison, James P. ;

Quezada, Sergio A. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (09) :1695-1710

[94] Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice [J].

Singh, Kailash ;

Hjort, Marcus ;

Thorvaldson, Lina ;

Sandler, Stellan .

SCIENTIFIC REPORTS, 2015, 5

[95] Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation [J].

Someya, Kazue ;

Nakatsukasa, Hiroko ;

Ito, Minako ;

Kondo, Taisuke ;

Tateda, Kenn-ichi ;

Akanuma, Takashi ;

Koya, Ikuko ;

Sanosaka, Tsukasa ;

Kohyama, Jun ;

Tsukada, Yu-ichi ;

Takamura-Enya, Takeji ;

Yoshimura, Akihiko .

INTERNATIONAL IMMUNOLOGY, 2017, 29 (08) :365-375

[96] TGF-β signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity [J].

Sun, Xiang ;

Cui, Yu ;

Feng, Haiyun ;

Liu, Haifeng ;

Liu, Xiaolong .

JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (12) :2819-2837

[97] Deacetylase inhibition promotes the generation and function of regulatory T cells [J].

Tao, Ran ;

de Zoeten, Edwin F. ;

Oezkaynak, Engin ;

Chen, Chunxia ;

Wang, Liqing ;

Porrett, Paige M. ;

Li, Bin ;

Turka, Laurence A. ;

Olson, Eric N. ;

Greene, Mark I. ;

Wells, Andrew D. ;

Hancock, Wayne W. .

NATURE MEDICINE, 2007, 13 (11) :1299-1307

[98] Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab [J].

Tarhini, Ahmad A. ;

Edington, Howard ;

Butterfield, Lisa H. ;

Lin, Yan ;

Shuai, Yongli ;

Tawbi, Hussein ;

Sander, Cindy ;

Yin, Yan ;

Holtzman, Matthew ;

Johnson, Jonas ;

Rao, Uma N. M. ;

Kirkwood, John M. .

PLOS ONE, 2014, 9 (02)

[99] Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer [J].

Tone, Yukiko ;

Furuuchi, Keiji ;

Kojima, Yoshitsugu ;

Tykocinski, Mark L. ;

Greene, Mark I. ;

Tone, Masahide .

NATURE IMMUNOLOGY, 2008, 9 (02) :194-202

[100] Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype [J].

Tran, Dat Q. ;

Ramsey, Heather ;

Shevach, Ethan M. .

BLOOD, 2007, 110 (08) :2983-2990

← 4 5 6 7 8 9 10 11 12 13 →